Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Asia Pac J Public Health ; 34(2-3): 247-248, 2022 03.
Article in English | MEDLINE | ID: covidwho-1546712

ABSTRACT

There is no international reporting of SARS-CoV-2 infections in health care workers (HCWs). Estimates suggest that a HCW dies every thirty minutes from COVID-19. This worsened the shortages and burnout of HCWs worldwide. Twenty months into the pandemic, Bhutan recorded over 2600 COVID-19 positive cases and three deaths. About 906 HCWs were directly involved in managing these laboratory confirmed cases but no infections occured amongst this group. This zero infection was possible through the clustered management of positive cases in four national COVID-19 centers, strategic deployment of HCWs, the uninterrupted provision of quality personal protective equipment (PPE) and repeated training on the correct use of PPE. This is an exemplary achievement for a small country with limited expertise and resources.


Subject(s)
COVID-19 , Pandemics , Bhutan/epidemiology , Health Personnel , Humans , Pandemics/prevention & control , SARS-CoV-2
2.
Am J Trop Med Hyg ; 102(6): 1205-1207, 2020 06.
Article in English | MEDLINE | ID: covidwho-602003

ABSTRACT

The initial cases of novel coronavirus disease-19 (COVID-19) in a country are of utmost importance given their impact on healthcare providers, the country's preparedness response, and the initial molding of the public perception toward this pandemic. In Bhutan, the index case was a 76-year-old immunocompromised man who had traveled from the United States and entered Bhutan as a tourist. He presented initially with vague gastrointerestinal symptoms and later a cough. His atypical presentation led to a delay in diagnosis, but ultimately he was isolated and tested. On confirming the diagnosis of COVID-19, the patient was isolated in a separate hospital with a dedicated medical care team. All contacts were traced and quarantined. The patient's respiratory status deteriorated despite broad-spectrum antivirals, antibiotics, and intensive supportive care. He required intubation and was given a trial of intravenous immunoglobulin to modulate his likely aberrant immune response. Subsequently, the patient's clinical status improved, and after 8 days of hospitalization, he was transferred out of the country, where he recovered. This was a learning experience for the treating medical staff, the government, and the people of Bhutan.


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/diagnostic imaging , Hyperlipidemias/diagnostic imaging , Hypertension/diagnostic imaging , Lung/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Aged , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , Betacoronavirus/drug effects , Bhutan , COVID-19 , Contact Tracing , Coronavirus Infections/drug therapy , Coronavirus Infections/immunology , Coronavirus Infections/pathology , Humans , Hyperlipidemias/drug therapy , Hyperlipidemias/immunology , Hyperlipidemias/pathology , Hypertension/drug therapy , Hypertension/immunology , Hypertension/pathology , Immunocompromised Host , Immunoglobulins, Intravenous/therapeutic use , Lung/drug effects , Lung/pathology , Lung/virology , Male , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/immunology , Pneumonia, Viral/pathology , SARS-CoV-2 , Tomography, X-Ray Computed , Travel , Treatment Outcome , Ultrasonography , United States
SELECTION OF CITATIONS
SEARCH DETAIL